Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

World Congress of Bronchology and Interventional Pulmonology 2026

We are excited to announce that the World Congress of Bronchology and Interventional Pulmonology 2026 will be hosted by the Thoracic Society of Australia and New Zealand in the vibrant city of Melbourne, Australia. We are excited to announce that...

3rd Global Summit on Heart and Cardiovascular Care 2026

3rd Global Summit on Heart and Cardiovascular Care” (Heart Congress 2026), taking place on November 26–27, 2026, in Barcelona, Spain as a HYBRID EVENT—offering participants the flexibility to join in person or virtually from anywhere across the...

6th International Conference on Cardiology 2026

on Cardiology. Held in the vibrant city of Bangkok, Thailand, this prestigious event will take place on November 13–14, 2026. 6th International Conference on Cardiology. Held in the vibrant city of Bangkok, Thailand, this prestigious event will...

Global Pharma Supply Chain & Logistics Forum 2026

The Global Pharma Supply Chain & Logistics Forum 2026 is a premier invite-only event uniting top pharma and healthcare supply chain leaders. The Global Pharma Supply Chain & Logistics Forum 2026 is a premier invite-only event uniting top pharma...

2nd International Conference on Drug Discovery 2026

The 2nd International Conference on Drug Discovery 2026, organized by Scisynopsis Conferences, aims to bring together researchers, scientists, industry leaders, and academicians from around the world to explore groundbreaking innovations in drug...

5th MENA Congress for Rare Diseases 2026

5th MENA Congress for Rare Diseases 2026 will take place from 3 to 5 September 2026 at Beach Rotana Hotel, Abu Dhabi, United Arab Emirates. 5th MENA Congress for Rare Diseases 2026 will take place from 3 to 5 September 2026 at Beach Rotana Hotel,...

Pharmacy Education 2026

Pharmacy Education 2026 is your chance to grow, learn, and lead. Don’t miss the professional development event everyone will be talking about—join us in Grapevine, Texas, July 18-21, for bold ideas, powerful connections, and real-world impact....

23rd International conference on Nanosciences and Nanotechnologies

NN Conference is a world-class International event in Nanosciences and Nanotechnologies (N&N) that focuses on the latest advances on N&N and promotes profound scientific discussions between scientists, researchers from different disciplines and...

DIA Global Annual Meeting

The DIA 2026 Global Annual Meeting is evolving, just like the life sciences community it serves. Join global innovators, regulators, academics, patient advocates, and industry leaders for an all-new experience designed to inspire, engage, and...

Digi-Tech Pharma & AI Conference 2026

The 9th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare...

Aspera Biomedicines launched its second ADAR1p150 crystallization to the ISS aboard SpaceX CRS-34

builds on Aspera’s inaugural ADAR1p150 crystallization experiment, which launched aboard SpaceX Crew-12 in February 2026. Funded through NASA’s In Space Production Applications (InSPA) Phase 2 award, the work uses Redwire Corporation’s...

A new real-world case series examines re-induction with ADSTILADRIN in clinical practice

included patients with carcinoma in situ (CIS), with or without papillary tumors (±Ta/T1). The findings – presented at the 2026 American Urological Association (AUA) Annual Meeting and scheduled for publication in Translational Andrology and...

Pathobiology 2026

Pathobiology 2026 – May 16-19, 2026, in Fort Myers, Florida. Similar to the past two Annual Meetings, Pathobiology 2026 will be a stand-alone meeting that will leverage our society’s unique strengths in the understanding of cellular and molecular...

Neurocritical care leaders will discuss NPi pupillometry in NeurOptics sessions at AACN NTI 2026.

CCRN, CNRN, SCRN, FAHA, FNCS, FCCM, will speak as part of NeurOptics' in-booth clinical education programming at AACN NTI 2026, May 17–20, in San Diego. NeurOptics will be exhibiting in Booth #1616. Olson will present "Evidence-Based Practice in...

SUANNUTRA USA secures U.S. distribution rights for TetraSOD.

safeguarded by 10 patents and backed by 17 peer-reviewed studies conducted since 2006, with the latest published in March 2026. Its efficacy at a daily dose of just 25 mg has been demonstrated in multiple human clinical trials, highlighting its...

MinuteClinic highlights improved access and outcomes through its clinically supervised weight-loss program

its clinically supervised weight-loss program to support earlier intervention and more accessible preventive care. As of 2026, the program has demonstrated strong outcomes: 85% of patients lost weight within their first three months About...

Avenacy Announces U.S. Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection

standards. U.S. sales of Tranexamic Acid Injection were approximately $30.2 million for the twelve months ending in March 2026, with ready-to-use presentations accounting for approximately $15 million of total sales.1 Indications Tranexamic Acid...

2nd Annual MaxPotent Pharma Summit 2026

2nd Annual MaxPotent Pharma Summit – a leading international platform bringing together senior executives, regulatory authorities, technology providers, and pharmaceutical innovators dedicated to advancing the future of Highly Potent Active...

Novo Nordisk’s Ozempic pill—the only FDA-approved oral peptide GLP-1 for adults with Type 2 Diabetes—will soon be available in the U.S

(semaglutide) tablets 25 mg for use in adults with type 2 diabetes. The company expects an FDA decision by the end of 2026. Do not use Ozempic® if: you or any of your family have ever had MTC, or if you have an endocrine system condition called...

UCB to acquire Candid Therapeutics, strengthening its immunology pipeline with novel T-cell engagers

including required anti-trust clearance and other customary conditions, and is expected to close by end of Q2 – early Q3 2026. Lazard is acting as financial advisor to UCB, and Covington & Burling LLP is serving as legal counsel to UCB. Jefferies...

Results 1 - 20 of 67